Document Detail


HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
MedLine Citation:
PMID:  20934897     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIM: Fasting plasma glucose (FPG) and the 2-h post-challenge plasma glucose (2hPG) are commonly used to identify those at risk of type 2 diabetes. However, the role of HbA(1c) in this prediction has still not been ascertained.
METHODS: The Asturias study is a prospective population-based survey of diabetes and cardiovascular risk factors. Baseline examination, carried out during 1998-1999, involved 1034 individuals, aged 30-75 years, randomly selected to determine the prevalence of type 2 diabetes and prediabetes in the principality of Asturias (northern Spain). In 2004-2005, these same subjects were invited to a follow-up examination, and 700 participated. The present study includes only those who did not have diabetes at baseline. All participants with no known diabetes underwent an OGTT. Baseline HbA(1c) levels were measured by HPLC.
RESULTS: Diabetes had developed in 44 participants at the time of follow-up. Quartiles of baseline HbA(1c) values were 3.4-4.8 (Q1), 4.9-5.1 (Q2), 5.2-5.4 (Q3) and 5.5-6.9 (Q4), and the incidence rates of diabetes by quartiles were 1.0 (0.1-7.1), 4.0 (1.5-10.7), 7.9 (4.0-15.9) and 32.6 (22.9-46.4) cases/1000 person-years, respectively. ROC curve analysis comparing HbA(1c), FPG and 2hPG in the prediction of diabetes showed areas under the curve (ROC-AUC) of 0.80 (0.74-0.86), 0.83 (0.77-0.90) and 0.79 (0.72-0.87), respectively. The combination of FPG and HbA(1c) had the best predictive performance with an ROC-AUC of 0.88 (0.82-0.93).
CONCLUSION: Our study indicates that HbA(1c) is strongly predictive of new-onset diabetes in this northern Spanish population, and was similar to FPG and 2hPG in predictive capability. Also, the combined measurement of FPG and HbA(1c) improved their individual predictive performance.
Authors:
S Valdés; P Botas; E Delgado; F Alvarez; F Díaz-Cadórniga
Related Documents :
10937507 - Plasma glucose and prediction of microvascular disease and mortality: evaluation of 199...
15057547 - Diabetes screening after gestational diabetes mellitus: poor performance of fasting pla...
20413967 - People with impaired glucose tolerance and impaired fasting glucose are similarly susce...
8858117 - A g-to-a substitution at nucleotide position 3316 in mitochondrial dna is associated wi...
182367 - Insulin: fundamental mechanism of action and the heart.
20173777 - Blockade of interleukin 1 in type 1 diabetes mellitus.
Publication Detail:
Type:  Journal Article     Date:  2010-10-08
Journal Detail:
Title:  Diabetes & metabolism     Volume:  37     ISSN:  1878-1780     ISO Abbreviation:  Diabetes Metab.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9607599     Medline TA:  Diabetes Metab     Country:  France    
Other Details:
Languages:  eng     Pagination:  27-32     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Masson SAS. All rights reserved.
Affiliation:
Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain; Endocrinology and Nutrition, Hospital Universitario Carlos Haya (Fundación IMABIS), Plaza del Hospital Civil, 29009 Malaga, Spain; Ciber de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Malaga, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pediatric sleep questionnaires as diagnostic or epidemiological tools: a review of currently availab...
Next Document:  Role of Ag ions on the structural evolution of nano ZnO clusters synthesized through ultrasonication...